Allergan Raises Forecast After Reporting Rising Sales of Botox
Allergan's flagship product, Botox.
Photographer: Jason Alden/Bloomberg
This article is for subscribers only.
Drugmaker Allergan Plc raised its full-year forecast on Tuesday after reporting rising sales of its flagship product, the anti-wrinkle injection Botox.